MedPath

Rad-67 Repeatability and Reproducibility

Completed
Conditions
Healthy
Interventions
Device: Rad-67 Pulse CO-Oximeter and DCI Mini sensor
Registration Number
NCT04196907
Lead Sponsor
Masimo Corporation
Brief Summary

The primary objective of this clinical investigation is to evaluate the repeatability and reproducibility of using Rad-67 Pulse CO-Oximeter

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • At least 18 years of age
  • Weight at least 110 pounds
  • Subjects with the intention of being screened for eligibility to donate blood
  • The subject has given written informed consent to participate in the study
Exclusion Criteria
  • Subjects with skin abnormalities at the planned application sites that may interfere with sensor application, per directions-for-use (DFU) or trans-illumination of the site, such as burns, scar tissue, infections, abnormalities, etc.
  • Subjects unwilling to remove nail polish or acrylic nails
  • Subjects with blood cancers such as leukemia
  • Subjects with hemoglobin disorders such as sickle-cell anemia and thalassemia or with known history of infectious diseases such as HIV/AIDS, syphilis, hepatitis, etc.
  • Subjects with self-disclosed/known pregnancy at the time of enrollment
  • Subjects deemed not suitable for the study at the discretion of the investigator
  • Subjects unlikely to be able to refrain from excessive motion during data collection. Excessive motion includes postural changes, making hand gestures, involuntary muscular movements, etc.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Test subjectsRad-67 Pulse CO-Oximeter and DCI Mini sensorAll subjects are enrolled and receive Rad-67 Pulse Oximeter and DCI Mini sensor for measurement of hemoglobin.
Primary Outcome Measures
NameTimeMethod
Variation Ratio of Total Repeatability and Reproducibility Hemoglobin Measurements Using Rad-67.1 hour

Quality of hemoglobin measurements is defined as a variance ratio of total Gage repeatability and reproducibility variance to total variance. Subject, operator and device were considered as components to calculate this ratio.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

San Diego Blood Bank

🇺🇸

San Diego, California, United States

© Copyright 2025. All Rights Reserved by MedPath